has been cited by the following article(s):
|
[1]
|
A 25-year-female with Diffuse Intrinsic Pontine Glioma Surviving for More than Nine Years Following Treatment with Antineoplastons
|
|
Cancer …,
2022 |
|
|
|
|
[2]
|
Long-term survival (23 years) in a 26-year-old male after Antineoplaston therapy for a progressive, diffuse intrinsic pontine glioma: A case report
|
|
Int J Brain Disord …,
2021 |
|
|
|
|
[3]
|
Resolution of clinical signs, a complete response, and long-term survival (> 23 Years) in a 3 and ½ month female with a newly diagnosed diffuse intrinsic …
|
|
Biomed Res,
2021 |
|
|
|
|
[4]
|
A Phase II Study of Antineoplastons A10 and AS2-1 in Children with Brain Tumors. Final Report (Protocol BT-10)
|
|
2017 |
|
|
|
|
[5]
|
Antineoplastons A10 and AS2-1 in the Treatment of Children with Optic Pathway Glioma: Final Report for Protocol BT-23
|
|
Cancer and Clinical Oncology,
2017 |
|
|
|
|
[6]
|
Primary CNS Tumors and Leptomeningeal, Disseminated and/or Multicentric Disease in Children Treated in Phase II Studies with Antineoplastons A10 …
|
|
2016 |
|
|
|
|
[7]
|
Primary CNS Tumors and Leptomeningeal, Disseminated and/or Multicentric Disease in Children Treated in Phase II Studies with Antineoplastons A10 and …
|
|
2016 |
|
|
|
|
[8]
|
A Phase II Study of Antineoplastons A10 and AS2-1 in Children with Low-Grade Astrocytomas—Final Report (Protocol BT-13)
|
|
2016 |
|
|
|
|
[9]
|
Primary CNS Tumors and Leptomeningeal, Disseminated and/or Multicentric Disease in Children Treated in Phase II Studies with Antineoplastons A10 and AS2-1
|
|
Cancer and Clinical Oncology,
2016 |
|
|
|
|
[10]
|
Comprehensive Genomic Profiling of Recurrent Classic Glioblastoma in a Patient Surviving Eleven Years Following Antineoplaston Therapy
|
|
Cancer and Clinical Oncology,
2015 |
|
|
|
|
[11]
|
Long-Term Survival Over 21 Years and Pathologically Confirmed Complete Response in Pediatric Anaplastic Astrocytoma: A Case Report
|
|
J Neurol Stroke,
2015 |
|
|
|
|
[12]
|
A Phase II Study of Antineoplastons A10 and AS2-1 in Adult Patients with Primary Brain Tumors—Final Report (Protocol BT-09)
|
|
Journal of Cancer Therapy,
2015 |
|
|
|
|
[13]
|
Newly-Diagnosed Multicentric Pilocytic Astrocytoma: Complete Response and> 22 Years Survival in a Six Year and Nine-Month-Old Female Treated with …
|
|
|
|
|
|
|
[1]
|
A Phase II Study of Antineoplastons A10 and AS2-1 in Children with Brain Tumors. Final Report (Protocol BT-10)
Journal of Cancer Therapy,
2017
DOI:10.4236/jct.2017.82015
|
|
|
|
|
[2]
|
A Phase II Study of Antineoplastons A10 and AS2-1 in Children with Low-Grade Astrocytomas—Final Report (Protocol BT-13)
Journal of Cancer Therapy,
2016
DOI:10.4236/jct.2016.712083
|
|
|
|
|
[3]
|
A Phase II Study of Antineoplastons A10 and AS2-1 in Adult Patients with Primary Brain Tumors—Final Report (Protocol BT-09)
Journal of Cancer Therapy,
2015
DOI:10.4236/jct.2015.612116
|
|
|
|
|
[4]
|
Long-Term Survival Over 21 Years and Pathologically Confirmed Complete Response in Pediatric Anaplastic Astrocytoma: A Case Report
Journal of Neurology & Stroke,
2015
DOI:10.15406/jnsk.2015.02.00072
|
|
|
|